Class II recall: Baxter Healthcare Corporation: CARDENE IV (Nicardipine Hydrochloride) in 0.83% Sodium Chloride Injection, 40 mg

The FDA has classified a Class II recall of Baxter Healthcare's Cardene IV (Nicardipine Hydrochloride) in 0.83% Sodium Chloride Injection, 40 mg in 200 mL, supplied in GALAXY Single-Dose Containers under NDC 43066-016-10. According to the recall notice, the action was initiated due to current good manufacturing practice (CGMP) deviations. The notice does not specify the nature of the deviations or additional details beyond the product identification and recall classification.

Most relevant for: patients receiving intravenous nicardipine for acute hypertension or acute coronary syndrome management

Summary written by an AI model from the source text and dated by the source's publication date. Check the original before acting on it. How MedFollow selects and summarizes updates.

Informational only. Not medical advice. Not a substitute for clinical judgment. Always consult current guidelines and your own clinical judgment.